Zobrazeno 1 - 10
of 982
pro vyhledávání: '"Tressler R"'
Autor:
Adam SJ; Foundation for the National Institutes of Health, North Bethesda, MD, USA., Buchman TG; Critical Care Center, Emory University School of Medicine, Atlanta, GA, USA., Currier JS; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Draghia-Akli R; The Janssen Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ, USA., Fessel JP; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA., Higgs ES; National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA., Hughes EA; Teva Pharmaceuticals, Parsippany, NJ, USA., LaVange L; Biostatistics, Gillings School of Global Public Health at the University of North Carolina at Chapel Hill, NC, USA., Menetski JP; Foundation for the National Institutes of Health, North Bethesda, MD, USA., Read SW; National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA., Rosenberg Y; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Tressler R; National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.
Publikováno v:
Journal of clinical and translational science [J Clin Transl Sci] 2024 Oct 15; Vol. 8 (1), pp. e150. Date of Electronic Publication: 2024 Oct 15 (Print Publication: 2024).
Autor:
Gay CL; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Bosch RJ; Department of Biostatistics, Center for Biostatistics and AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., McKhann A; Department of Biostatistics, Center for Biostatistics and AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Cha R; Center for Integrated Global Biomedical Sciences, University at Buffalo, Buffalo, New York, USA., Morse GD; Center for Integrated Global Biomedical Sciences, University at Buffalo, Buffalo, New York, USA., Wimbish CL; Department of Clinical Research, Social and Scientific Systems, Inc, a DLH Company, Silver Spring, Maryland, USA., Campbell DM; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA., Moseley KF; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Hendrickx S; Department of Medicine, University of California, San Diego, San Diego, California, USA., Messer M; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Benson CA; Department of Medicine, University of California, San Diego, San Diego, California, USA., Overton ET; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; North America Medical Affairs, ViiV Healthcare, Durham, North Carolina, USA., Paccaly A; Departments of Clinical Sciences, Translational Medicine and Precision Medicine, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Jankovic V; Departments of Clinical Sciences, Translational Medicine and Precision Medicine, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Miller E; Departments of Clinical Sciences, Translational Medicine and Precision Medicine, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Tressler R; HIV Research Branch, Division of AIDS, National Institute of AIDS, National Institutes of Health, Rockville, Maryland, USA., Li JZ; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Kuritzkes DR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Macatangay BJC; Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Eron JJ; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Hardy WD; Division of Infectious Diseases, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 11; Vol. 11 (3), pp. ofad694. Date of Electronic Publication: 2024 Jan 11 (Print Publication: 2024).
Autor:
Miller, V., Pantaleo, G., Tiemessen, C.T., Kuritzkes, D., Schacker, T., Stephenson, K., Julg, B., Sugarman, J., Colby, D.J., Sogaard, O.S., Dee, L., Ananworanich, J., Nixon, D.F., Michael, N.L., Johnston, R., Dube, K., Palm, D., Goulder, P., Jefferys, R., Tressler, R., Dawson, L., Likhitwonnawut, U., Spudich, S., Tebas, P., Eron, J., Robb, M.L., Frater, J., Weiss, C.D., Sheikh, V., Barouch, D.H., van Lunzen, J., Peay, H., Geleziunas, R., Zheng, L., Deeks, S.G., Bar, K., Hanna, G.J., Martinez-Picado, J., Walker, B.D., Salzwedel, K., Mellors, J.W., Dong, K.L., Li, J.Z., Gandhi, R.T., Salzwedel, J., Taylor, J., Caskey, M., Persaud, D., Montaner, L.J.
Analytical antiretroviral treatment interruption (ATI) is an important feature of HIV research, seeking to achieve sustained viral suppression in the absence of antiretroviral therapy (ART) when the goal is to measure effects of novel therapeutic int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5cda017c1af76809ae144bab45f7483
Autor:
Hurley, C., AIDS Clinical Trials Group A5342 Protocol Team, Ritz, J., Storey, S., Gottesman, J., Sbrolla, A., Macatangay, B.J.C., Kessels, L., Arduino, R.C., Acosta, Ed., Perelson, A., Ray, G., Eron, J.J., Ledgerwood, J., Baer, J., Zheng, L., Lambert, N., Kudumu, M., Koup, R.A., Campbell, D., Tipton, M., Bunce, C.A., Epperson, K., Villamil, A.E., Sise, T., Casazza, J., Jennings, C., Dunaway, S., Tressler, R., Nair, A., Leonard, M., Cyktor, J.C., Bailer, R.T., Hite, M., Howard, J., Muttera, L., Clark, J., Weinman, R., Mellors, J.W., Durand, C.M., Koletar, S.L., Flynn, T., Benns, A., Keefer, M.C., Berzins, B., Currin, D., Riddler, S.A., Benson, C., Kittelson, P., Spitz, T., Wiggins, I., Onesi, S.
Background. Broadly neutralizing monoclonal antibodies (bnMAbs) may promote clearance of HIV-1-expressing cells through antibody-dependent cell-mediated cytotoxicity. We evaluated the effect of the CD4-binding site bnMAb, VRC01, on measures of HIV-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b93056666a9b7c3b36000d63201c3c0e
Autor:
Marconi VC; Emory University School of Medicine, Atlanta, Georgia, USA.; Emory University Rollins School of Public Health, Atlanta, Georgia, USA.; Atlanta Veterans Affairs Medical Center, Decatur, Georgia, USA.; Emory Vaccine Center, Atlanta, Georgia, USA., Moser C; Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Gavegnano C; Emory University School of Medicine, Atlanta, Georgia, USA., Deeks SG; University of California, San Francisco, San Francisco, California, USA., Lederman MM; Case Western Reserve University, Cleveland, Ohio, USA., Overton ET; University of Alabama at Birmingham, Birmingham, Alabama, USA., Tsibris A; Harvard Medical School, Boston, Massachusetts, USA., Hunt PW; University of California, San Francisco, San Francisco, California, USA., Kantor A; Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Sekaly RP; Case Western Reserve University, Cleveland, Ohio, USA., Tressler R; National Institutes of Health, Bethesda, Maryland, USA., Flexner C; Johns Hopkins University, Baltimore, Maryland, USA., Hurwitz SJ; Emory University School of Medicine, Atlanta, Georgia, USA., Moisi D; Case Western Reserve University, Cleveland, Ohio, USA., Clagett B; Case Western Reserve University, Cleveland, Ohio, USA., Hardin WR; Duke University, Durham, North Carolina, USA., Del Rio C; Emory University School of Medicine, Atlanta, Georgia, USA.; Emory University Rollins School of Public Health, Atlanta, Georgia, USA., Schinazi RF; Emory University School of Medicine, Atlanta, Georgia, USA., Lennox JJ; Emory University School of Medicine, Atlanta, Georgia, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Jan 07; Vol. 74 (1), pp. 95-104.
Autor:
Gay CL; Division of Infectious Diseases, the University of North Carolina at Chapel Hill, Chapel Hill, NC., Bosch RJ; Department of Biostatistics, Center for Biostatistics and AIDS Research,Harvard T. H. Chan School of Public Health, Boston, MA., McKhann A; Department of Biostatistics, Center for Biostatistics and AIDS Research,Harvard T. H. Chan School of Public Health, Boston, MA., Moseley KF; Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD., Wimbish CL; Department of Clinical Research, Social and Scientific Systems, Inc, a DLH Company, Silver Spring, MD., Hendrickx SM; Division of Infectious Diseases, University of California, San Diego, CA., Messer M; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL., Furlong M; Division of Infectious Diseases, the University of North Carolina at Chapel Hill, Chapel Hill, NC., Campbell DM; Semel Institute for Neuroscience and Human Behavior, Center for AIDS Research and Education (CARE), University of California, Los Angeles, CA., Jennings C; Division of Infectious Diseases, Northwestern University, Chicago, IL., Benson C; Division of Infectious Diseases, University of California, San Diego, CA., Overton ET; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL., Macatangay BJC; Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA., Kuritzkes DR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Miller E; Clinical Sciences, Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, NY., Tressler R; HIV Research Branch, Division of AIDS, National Institute of AIDS, National Institutes of Health, Rockville, MD., Eron JJ; Division of Infectious Diseases, the University of North Carolina at Chapel Hill, Chapel Hill, NC., Hardy WD; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD.
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2021 Aug 15; Vol. 87 (5), pp. e234-e236.
Publikováno v:
Journal of the International AIDS Society. Oct2024 Supplement 1, Vol. 27, p1-92. 92p.
Publikováno v:
Journal of Applied Physics; Oct1983, Vol. 54 Issue 10, p5739-5743, 5p
Autor:
Friis-Moller, N, Sabin, CA, Weber, R, Monforte, AD, El-Sadr, WM, Reiss, P, Thiebaut, R, Morfeldt, L, De Wit, S, Pradier, C, Calvo, G, Law, MG, Kirk, O, Phillips, AN, Lundgren, JD, Monteforte, AD, Bartsch, G, Dabis, F, Houyez, F, Loeliger, E, Tressler, R, Weller, I., Sjol, A, Sawitz, A, Rickenbach, M, Pezzotti, P, Krum, E, Meester, R, Lavignolle, V., Mulder, J, van der Meer, J, Sprenger, HG, Koopmans, P, Borleffs, J, Crane, LR, Johnson, MA, Martinelli, C
Publikováno v:
New England Journal of Medicine, 349(21), 1993-2003. MASSACHUSETTS MEDICAL SOC
New England journal of medicine, 349(21), 1993-2003. Massachussetts Medical Society
The New England journal of medicine, 349(21), 1993-2003. Massachussetts Medical Society
New England journal of medicine, 349(21), 1993-2003. Massachussetts Medical Society
The New England journal of medicine, 349(21), 1993-2003. Massachussetts Medical Society
BACKGROUND: It remains controversial whether exposure to combination antiretroviral treatment increases the risk of myocardial infarction. METHODS: In this prospective observational study, we enrolled 23,468 patients from 11 previously established co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9acc87eedaf09e36cd4f177a05a010
https://doi.org/10.1056/nejmoa030218
https://doi.org/10.1056/nejmoa030218
Autor:
Li JZ; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Segal FP; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Bosch RJ; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Lalama CM; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Roberts-Toler C; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Delagreverie H; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Service de Microbiologie, Universite Paris Diderot, Paris, France., Getz R; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Garcia-Broncano P; Ragon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Cambridge., Kinslow J; Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois., Tressler R; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., Van Dam CN; Regional Center for Infectious Disease, Cone Health, Greensboro, North Carolina., Keefer M; Division of Infectious Diseases, University of Rochester School of Medicine and Dentistry, New York., Carrington M; Ragon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Cambridge.; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Lichterfeld M; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Kuritzkes D; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Yu XG; Ragon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Cambridge., Landay A; Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois., Sax PE; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Apr 10; Vol. 70 (8), pp. 1636-1642.